Measuring Carboplatin Levels in Melanoma Using Microdialysis
Author Information
Author(s): B Blochl-Daum, M Miller, V Meisinger, HG Eichler, A Fassolt, H Pehamberger
Primary Institution: Vienna University Hospital
Hypothesis
Microdialysis can effectively measure carboplatin concentration profiles in melanoma tumors.
Conclusion
Microdialysis is a valuable tool for measuring drug concentrations in solid tumors, providing insights into pharmacokinetics.
Supporting Evidence
- Microdialysis allowed for the estimation of key pharmacokinetic parameters in the extracellular fluid of tumors.
- Mean carboplatin concentrations in tumors were only 50-60% of serum levels.
- Microdialysis was well tolerated by all patients with no adverse events reported.
Takeaway
This study shows that a special technique can help doctors see how much medicine gets into tumors, which is important for treating cancer.
Methodology
Microdialysis was used to sample carboplatin concentrations in serum, tumor, and subcutaneous tissue from six patients.
Limitations
The study's findings may not represent the entire tumor due to the placement of only one probe.
Participant Demographics
Six platinum-naive patients (4 female, 2 male) with a mean age of 58 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website